Merck KGaA (XTER:MRK) Additional Paid-In Capital : €3,814 Mil(As of Dec. 2023)

View and export this data going back to 1995. Start your Free Trial

What is Merck KGaA Additional Paid-In Capital?

Merck KGaA's quarterly additional paid-in capital stayed the same from Jun. 2023 (€3,814 Mil) to Sep. 2023 (€3,814 Mil) and stayed the same from Sep. 2023 (€3,814 Mil) to Dec. 2023 (€3,814 Mil).

Merck KGaA's annual additional paid-in capital stayed the same from Dec. 2021 (€3,814 Mil) to Dec. 2022 (€3,814 Mil) and stayed the same from Dec. 2022 (€3,814 Mil) to Dec. 2023 (€3,814 Mil).

Merck KGaA Additional Paid-In Capital Historical Data

The historical data trend for Merck KGaA's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merck KGaA Additional Paid-In Capital Chart

Merck KGaA Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

Get a 7-Day Free Trial

3,814.00

Merck KGaA Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Additional Paid-In Capital	Get a 7-Day Free Trial															3,814.00	3,814.00	3,814.00	3,814.00	3,814.00

Merck KGaA Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Merck KGaA Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Merck KGaA's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Merck KGaA (XTER:MRK) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merck KGaA (XTER:MRK) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

MKKGY:USA MKGAF:USA MRK:Italy MRKd:UK 0O14:UK MRCK:Austria

Address

Frankfurter Strasse 250, Darmstadt, HE, DEU, 64293

Website

https://www.emdgroup.com

Merck KGaA operates in three main segments: life sciences, performance materials, and healthcare. The life sciences segment (47% of 2022 sales) primarily provides laboratory consumables and services to researchers in academia and applied fields, including the biopharmaceutical industry. In the healthcare segment (35%), Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In its electronics segment (18%), the company offers specialty materials to manufacture a variety of products, such as semiconductors, flat-screen televisions, automobiles, and cosmetics. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.

Executives

Belén Garijo Lopez	Chair of the Executive Board
Peter Guenter	Member of the Executive Board
Dr. Matthias Heinzel	Member of the Executive Board
Dr. Marcus Kuhnert	Board of Directors